HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Classifying health-related quality of life outcomes of total hip arthroplasty.

AbstractBACKGROUND:
Primary total hip arthroplasty (THA) is an effective treatment for hip osteoarthritis, assessed by whatever distribution-based measures of responsiveness. Yet, the group level evaluation has provided very little evidence contributes to our understanding of the large variation of treatment outcome. The objective is to develop criteria that classify individual treatment health related quality of life (HRQOL) outcome after primary THA, adjusted by preoperative scores.
METHODS:
We prospectively measured 147 patients' disease specific HRQOL on the date of consultation and 12 months post operation by Western Ontario McMaster Universities Osteoarthritis Index (WOMAC). Regression models were used to determine the "expected" outcome for a certain individual baseline score. The ceiling effect of WOMAC measurement is addressed by implementing a left-censoring method.
RESULTS:
The classification criteria are chosen to be the lower boundary of the 95% confidence interval (CI) of the estimated median from the regression. The robustness of the classification criteria was demonstrated using the Monte-Carlo simulation.
CONCLUSION:
The classification criteria are robust and can be applied in general orthopaedic research when the sample size is reasonable large (over 500).
AuthorsMin Xu, Donald S Garbuz, Lisa Kuramoto, Boris Sobolev
JournalBMC musculoskeletal disorders (BMC Musculoskelet Disord) Vol. 6 Pg. 48 (Sep 06 2005) ISSN: 1471-2474 [Electronic] England
PMID16144550 (Publication Type: Journal Article)
Topics
  • Aged
  • Arthroplasty, Replacement, Hip
  • Female
  • Health Status
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Osteoarthritis, Hip (physiopathology, surgery)
  • Postoperative Period
  • Prospective Studies
  • Quality of Life
  • Surveys and Questionnaires
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: